SANOFI-AVENTIS U.S. LLC

Sanofi-Aventis U.S. LLC specializes in the manufacturing of pharmaceutical preparations, with a demonstrated focus on producing specialized therapeutics for complex clinical needs, including hematology and immunotherapy products. Their technical expertise lies in GMP-compliant drug formulation, aseptic processing, and end-to-end pharmaceutical production systems that meet stringent FDA and federal regulatory standards. The company’s capabilities center on the scalable, reliable manufacturing of injectable biologics and specialty pharmaceuticals, particularly for niche indications requiring precise dosing and cold-chain integrity. Their operational model emphasizes batch consistency, regulatory documentation rigor, and supply chain resilience critical to federal healthcare delivery. The contractor maintains a consistent relationship with the Department of Veterans Affairs, supplying critical pharmaceuticals under Blanket Purchase Agreements and Federal Supply Schedule contracts. These engagements reflect a trusted role in supporting veteran healthcare through the provision of high-complexity, low-volume therapeutics, including specialty drugs for autoimmune and hematologic conditions. The nature of these awards suggests deep alignment with VA’s mission to ensure uninterrupted access to advanced, life-sustaining medications for enrolled beneficiaries. The primary NAICS code 325412 reflects core competency in pharmaceutical preparation manufacturing, specifically the production of finished dosage forms such as injectables, oral solids, and biologics derived from active pharmaceutical ingredients. This positions the contractor within the specialty pharma vertical, serving government healthcare systems requiring clinically advanced, non-commodity medications. Their market role is that of a high-assurance supplier to federal medical programs requiring validated, traceable manufacturing processes. Sanofi-Aventis U.S. LLC operates as a 2L entity based in Bridgewater, New Jersey, with no public certifications listed. The company’s government market presence is defined by its physical manufacturing infrastructure and regulatory compliance posture, enabling it to serve as a qualified supplier for federal pharmaceutical procurement programs without reliance on small business or socio-economic designations.